Baxter International Inc (BAX)

53.43
0.02 0.04
NYSE : Health Care
Prev Close 53.45
Open 53.29
Day Low/High 53.04 / 53.62
52 Wk Low/High 42.22 / 53.71
Volume 3.39M
Avg Volume 2.93M
Exchange NYSE
Shares Outstanding 541.96M
Market Cap 28.66B
EPS 9.10
P/E Ratio 5.82
Div & Yield 0.52 (1.00%)

Latest News

Baxter To Present At The UBS Global Healthcare Conference

Baxter To Present At The UBS Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the UBS Global Healthcare Conference on Tuesday, May 23, 2017 in New York.

Baxter To Present At The Bank Of America Merrill Lynch Healthcare Conference

Baxter To Present At The Bank Of America Merrill Lynch Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 16, 2017 in Las Vegas.

Cramer: These Stocks Look Like 'Easy Pickings'

Cramer: These Stocks Look Like 'Easy Pickings'

From Aetna to United Technologies, these names are hot.

These 'Rocket Stocks' Look Ready for Blastoff

These 'Rocket Stocks' Look Ready for Blastoff

These four stocks are showing short-term gain catalysts and longer-term growth potential.

These 4 'Rocket Stocks' Look Ready for Blastoff

These 4 'Rocket Stocks' Look Ready for Blastoff

These four stocks are showing short-term gain catalysts and longer-term growth potential.

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Baxter International Inc. To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. (NYSE:BAX) will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 2, 2017 at 9:00 a.

FLOSEAL Hemostatic Matrix (Photo: Business Wire)

FLOSEAL Hemostatic Matrix (Photo: Business Wire)

Baxter International Inc. (NYSE: BAX) is committed to advancing surgical innovation and unveiled new designs that enhance the company's FLOSEAL and TISSEEL hemostatic products at the Association of periOperative Registered...

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

Baxter International Inc. To Host First Quarter 2017 Financial Results Conference Call For Investors

Baxter International Inc. To Host First Quarter 2017 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE:BAX), will host a quarterly conference call to discuss its first quarter 2017 financial results on Wednesday, April 26, 2017, at 7:30 a.

Baxter's Chart Is Still Bullish

Baxter's Chart Is Still Bullish

Our price objective is $68.

Baxter And The Institute For Safe Medication Practices (ISMP) Address Global Medication Error Prevention

Baxter And The Institute For Safe Medication Practices (ISMP) Address Global Medication Error Prevention

The Institute for Safe Medication Practices (ISMP), with the support of Baxter International, is launching a two-year International Safe Medication Management Fellowship program.

New Data Indicates Use Of Baxter's FLOSEAL In Cardiac And Spinal Surgeries May Be Associated With Lower Hospital Costs

New Data Indicates Use Of Baxter's FLOSEAL In Cardiac And Spinal Surgeries May Be Associated With Lower Hospital Costs

Baxter International Inc. (NYSE: BAX) announced publication of the results of two health economic analyses in the Journal of Medical Economics supporting FLOSEAL Hemostatic Matrix as a cost-effective tool for controlling...

Baxter International Becomes #240 Most Shorted S&P 500 Component, Replacing Universal Health Services

Baxter International Becomes #240 Most Shorted S&P 500 Component, Replacing Universal Health Services

The most recent short interest data has been released for the 02/28/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

An Estimated One In 10 People Around The World Have Chronic Kidney Disease. Watch This Video To Learn More About Kidney Disease.

An Estimated One In 10 People Around The World Have Chronic Kidney Disease. Watch This Video To Learn More About Kidney Disease.

Baxter International Inc. (NYSE: BAX), a global innovator in renal care for more than 60 years, is a proud supporter of World Kidney Day, an education campaign focused on reducing the frequency and impact of kidney disease.

Baxter To Present At The Barclays Global Healthcare Conference

Baxter To Present At The Barclays Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017 in Miami.

Looking for Value Plays, Retail Stocks Can Be Excluded

Looking for Value Plays, Retail Stocks Can Be Excluded

Five names to consider from my 'stocks for the defensive investor' screen. Excluding retail, as the sector has generally produced poor results.

Retail Stocks Don't Make Good Value Plays

Retail Stocks Don't Make Good Value Plays

Five names to consider from my 'stocks for the defensive investor' screen.

Baxter And ScinoPharm Announce Exclusive Strategic Partnership For Generic Oncology Injectables

Baxter And ScinoPharm Announce Exclusive Strategic Partnership For Generic Oncology Injectables

Baxter International Inc. (NYSE: BAX) and ScinoPharm Taiwan, Ltd.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Baxter International Maintains Its Long-Running Uptrend

Baxter International Maintains Its Long-Running Uptrend

Recent upside breakout refreshes bull trend.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Baxter Declares Quarterly Dividend

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX) today announced a quarterly dividend.

Baxter Announced Today The Expansion Of Its Nutrition Care Portfolio To Include The New Enteral ENFit Syringes, Which Were Designed To Improve Patient Safety During Enteral Nutrition Therapy By Preventing Misconnections Or Wrong-route Administration That Can Cause Severe Patient Injury. (Photo: Business Wire)

Baxter Announced Today The Expansion Of Its Nutrition Care Portfolio To Include The New Enteral ENFit Syringes, Which Were Designed To Improve Patient Safety During Enteral Nutrition Therapy By Preventing Misconnections Or Wrong-route Administration That Can Cause Severe Patient Injury. (Photo: Business Wire)

Baxter International Inc. (NYSE: BAX), a global leader in nutrition therapy, announced today the expansion of its nutrition care portfolio to include the new enteral ENFit ® syringe and accessory line for patients...

Baxter To Present At The 38th Annual Raymond James Institutional Investor Conference

Baxter To Present At The 38th Annual Raymond James Institutional Investor Conference

Baxter International Inc. (NYSE: BAX) will present at the 38th Annual Raymond James Institutional Investor Conference on Tuesday, March 7, 2017 in Orlando.

Baxter To Present At The 37th Annual Cowen And Company Healthcare Conference

Baxter To Present At The 37th Annual Cowen And Company Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the 37th Annual Cowen and Company Healthcare Conference on Monday, March 6, 2017 in Boston.